Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page footer now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects a minor system/template update rather than a substantive change to the study details.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5. This represents a new platform build release, typically reflecting maintenance or bug fixes rather than changes to study details.SummaryDifference0.0%

- Check38 days agoChange DetectedA Publications section and a Study Results entry were added, including a citation for the IPROC sub-studies results. The page shows a new revision tag (v3.6.4) dated 2026-07-20, updating the study record with recent results dissemination.SummaryDifference0.4%

- Check45 days agoChange DetectedThe listing now identifies ovarian cancer as the condition, links related topics, and updates the study's location count to 6 locations with milestone dates such as 2026-07-14 and 2026-12-31. Additionally, outdated contact details and a Montreal location entry were removed, accompanying a change in reported locations from 7 to 6 and a revised recruitment status.SummaryDifference0.8%

- Check52 days agoChange DetectedThe page no longer lists 'Ovarian cancer' under related topics and the MedlinePlus Genetics link in the related resources. This reduces disease-focused context and access to consumer health information on ovarian cancer.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page shows a new revision label v3.6.3 replacing the previous v3.6.2, indicating a small, non-content related update to the page.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.